Pathology: squamous - mNSCLC - L1 - all population;
squamous - mNSCLC - L1 - all population | |||
IMpower-131 (ACnP), 2020 | IMpower-131 (ACP) EXPLORATORY, 2020 | ||
atezolizumab plus carboplatin plus nab-paclitaxel | 1 | T1 | |
atezolizumab plus carboplatin plus paclitaxel | 1 | T1 | |
carboplatin plus nab-paclitaxel | 0 | T0 | |
nab-paclitaxel | 0 | T0 |